6-(2-chlorophenyl)-3-(4-morpholin-4-yl-3-pyridinyl)-4a,7a-dihydro-1H-thieno[3,2-d]pyrimidine-2,4-dione
C21H19ClN4O3S — CID 171902731
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(2-chlorophenyl)-3-(4-morpholin-4-yl-3-pyridinyl)-4a,7a-dihydro-1H-thieno[3,2-d]pyrimidine-2,4-dione
6-(2-chlorophenyl)-3-(4-morpholin-4-yl-3-pyridinyl)-4a,7a-dihydro-1H-thieno[3,2-d]pyrimidine-2,4-dione (PubChem CID 171902731) has the molecular formula C21H19ClN4O3S and a molecular weight of 442.93 g/mol. Its IUPAC name is 6-(2-chlorophenyl)-3-(4-morpholin-4-yl-3-pyridinyl)-4a,7a-dihydro-1H-thieno[3,2-d]pyrimidine-2,4-dione.
Molecular Properties
| Compound Name | 6-(2-chlorophenyl)-3-(4-morpholin-4-yl-3-pyridinyl)-4a,7a-dihydro-1H-thieno[3,2-d]pyrimidine-2,4-dione |
|---|---|
| PubChem CID | 171902731 |
| Molecular Formula | C21H19ClN4O3S |
| Molecular Weight | 442.93 g/mol |
| Exact Mass | 442.09 |
| IUPAC Name | 6-(2-chlorophenyl)-3-(4-morpholin-4-yl-3-pyridinyl)-4a,7a-dihydro-1H-thieno[3,2-d]pyrimidine-2,4-dione |
| SMILES | O=C1NC2C=C(c3ccccc3Cl)SC2C(=O)N1c1cnccc1N1CCOCC1 |
| InChI | InChI=1S/C21H19ClN4O3S/c22-14-4-2-1-3-13(14)18-11-15-19(30-18)20(27)26(21(28)24-15)17-12-23-6-5-16(17)25-7-9-29-10-8-25/h1-6,11-12,15,19H,7-10H2,(H,24,28) |
| InChIKey | ANNROWBTZLFHNE-UHFFFAOYSA-N |
| XLogP | 3.15 |
| TPSA | 74.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 442.93 |
| LogP ≤ 5 | 3.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171902731 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.